Continuous renal replacement therapy Clinical Trials

4 recruitingLast updated: May 5, 2026

There are 7 actively recruiting continuous renal replacement therapy clinical trials across 5 countries. Studies span Not Applicable, Phase 2, Phase 3. Top locations include Atlanta, Georgia, United States, Barcelona, Barcelona, Spain, Birmingham, Alabama, United States. Updated daily from ClinicalTrials.gov.


Continuous renal replacement therapy Trials at a Glance

7 actively recruiting trials for continuous renal replacement therapy are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Atlanta, Barcelona, and Birmingham. Lead sponsors running continuous renal replacement therapy studies include Centre Hospitalier de Valenciennes, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, and Centre Hospitalier Universitaire de Nīmes.

Browse continuous renal replacement therapy trials by phase

About Continuous renal replacement therapy Clinical Trials

Looking for clinical trials for Continuous renal replacement therapy? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Continuous renal replacement therapy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Continuous renal replacement therapy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 3

Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

Acute Kidney Injury (AKI)Regional Citrate Anticoagulation (RCA)Continuous Renal Replacement Therapy (CRRT)
Vantive Health LLC40 enrolled14 locationsNCT05399537
Recruiting
Phase 2

Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU)

Continuous Renal Replacement Therapy (CRRT)
Zhujiang Hospital92 enrolled1 locationNCT07469072
Recruiting
Not Applicable

Validation of a Regional Citrate Anticoagulation Protocol in Critically Ill Patients on Continuous Renal Replacement Therapy

Acute Kidney InjuryICU PatientsContinuous Renal Replacement Therapy (CRRT)+1 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau43 enrolled1 locationNCT07514650
Recruiting
Not Applicable

Post-Filter Hematocrit

Continuous renal replacement therapyRenal FailureHemofilter Clotting
Gwyndolyn M. Radford20 enrolled1 locationNCT07293936
Recruiting
Not Applicable

Continuous Veno-venous Hemodialysis and Continuous Veno-venous Hemodiafiltration on Urea Reduction Rate in Intensive Care Patient

Continuous renal replacement therapyAcute Kidney InjuryIntensive Care Unit
Centre Hospitalier Universitaire de Nīmes80 enrolled1 locationNCT06369064
Recruiting
Phase 2Phase 3

Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients

Acute Kidney Injury Requiring Continuous Renal Replacement Therapy
Jikei University School of Medicine400 enrolled9 locationsNCT06014801
Recruiting

Beta-Lactams Dosing In Pneumonia in ICU in Patients Treated by Continuous Renal Replacement Therapy: the BLIPIC Study

Continuous renal replacement therapyPneumoniaBeta-lactam+1 more
Centre Hospitalier de Valenciennes65 enrolled1 locationNCT03897582